Who Owns agilon health Company?

agilon health Bundle

Get Full Bundle:

	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10
	SWOT	$15	$10

TOTAL:

ADD TO CART

Who owns agilon health now?

When agilon health went public in April 2021 it shifted from private-equity backing to broad institutional ownership, transforming governance and strategy toward value-based senior care. Founded in 2016, agilon partners with primary care groups to manage Medicare Advantage lives under capitated models.

Today ownership is concentrated among large institutional investors and public float holders; the board and major holders shape control, while policy and market flows affect voting power. See agilon health Porter's Five Forces Analysis for strategic context.

Founders and Early Ownership of agilon health: agilon health launched in 2016 with majority capital and sponsorship from Clayton, Dubilier & Rice (CD&R), which partnered with experienced healthcare operators and physician groups to build a capitated, physician‑centric platform.

Private equity sponsor

CD&R provided majority capital at formation and controlled the founding ownership structure while aligning management and physicians through rollover and incentive equity.

Executive architects

Ronald A. Williams and Ronald A. Kuerbitz led early strategy, designing the capitated model and serving in senior leadership and board roles.

Physician alignment

Partner physician groups received equity interests tied to long‑term contracts to align incentives with network performance and patient outcomes.

Management equity terms

Management equity was structured with multi‑year vesting and performance conditions typical of sponsor‑backed healthcare platforms.

Governance protections

Early agreements included buy‑sell mechanisms and call/put provisions to manage partner exits, preserve network stability, and protect sponsor capital.

Public disclosure

Precise founding share percentages were not publicly disclosed; CD&R funds held a controlling stake at inception and no material founding disputes were publicly reported.

Early capital deployment focused on building core markets, codifying physician partnership economics, and scaling value‑based, capitated contracts across Medicare Advantage and risk arrangements.

Key facts and structure

Founding ownership and governance highlights for agilon health:

• Formed in 2016 with majority sponsorship by CD&R; sponsor controlled initial equity.
• Founding leadership included Ronald A. Williams (board chair role later) and Ronald A. Kuerbitz.
• Physician groups acquired equity tied to long‑term contracts and performance metrics.
• Equity featured rollover equity, incentive equity, vesting schedules, and buy/sell clauses to manage exits.

For a concise corporate timeline and expansion details, see Brief History of agilon health

agilon health SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

Key events reshaping agilon health ownership include CD&R's founding majority control and private capital raises (2016–2020), the April 15, 2021 IPO at $23 per share that opened a public float, subsequent follow-on secondary sell‑downs through 2021–2023, and institutional consolidation amid 2024–2025 market repricing and Medicare Advantage volatility.

Ownership evolution shifted agilon health from a sponsor‑led private model to a predominantly institutionally held public company, increasing governance independence and market sensitivity to Medicare Advantage trends and quarterly guidance.

Major institutional holders and implications

By 2024–2025, institutional investors dominated the register, while insiders and CD&R held materially reduced stakes due to cumulative secondary sell‑downs.

• The Vanguard Group — typically a top holder in AGL filings
• BlackRock, Inc. — large passive and active mandates
• Capital Research & Management (Capital Group) — active ownership
• Wellington Management and T. Rowe Price — prominent active buyers

Strategic impact: the move from sponsor control to broad institutional ownership increased emphasis on independent board oversight, short‑term earnings cadence, and sensitivity to payer policy, utilization trends, and medical cost management; for further competitive context see Competitors Landscape of agilon health.

agilon health PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

As of 2025 the agilon health board blends independent healthcare operators, former payor/provider executives, private equity advisors and physician-alignment experts; Ronald A. Williams has served as board chair and CEO Steven Sell sits as a director amid a majority of independent directors.

The board composition supports physician-alignment strategy and scalable risk-bearing operations while CD&R-related seats declined after the IPO; governance priorities include compensation tied to medical margin, growth in senior lives under management and risk‑adjusted outcomes.

Board and Voting Snapshot

Voting power follows a one-share‑one‑vote common stock structure with no dual‑class shares or golden share; control equals economic ownership.

• agilon health ownership is proportional to shareholdings; no super‑voting shares exist
• Major shareholders include institutional investors and former private equity holders who reduced stakes post‑IPO
• Recent proxy seasons focused on pay‑for‑performance tied to medical margin and senior lives growth
• See governance and investor dynamics in the Marketing Strategy of agilon health

agilon health Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Ownership of agilon health shifted markedly from a legacy sponsor-dominated structure toward a more diversified institutional base between 2022 and 2025, driven by secondary offerings and sector-driven flows that increased passive and specialist healthcare ownership while insider stakes declined to low-single digits.

Institutional holders—large index funds and healthcare-focused managers—now account for the majority of publicly tradable shares, while voting power is dispersed and governance remains classic public-company control rather than dual-class or recapitalized structures; see Mission, Vision & Core Values of agilon health for corporate context.

Secondary offerings

Follow-on sales in 2022–2024 materially increased free float and lowered legacy sponsor concentration, enabling broader institutional participation.

Index and passive flows

Index rebalancings and passive ETF inflows elevated passive ownership weight, especially during 2023–2024 MA volatility periods.

Active manager rotation

Some growth-oriented active managers trimmed exposure while value and healthcare specialists increased stakes amid margin and utilization debates.

Insider and governance status

Aggregate insider ownership fell into the low-single digits by 2024/2025; the company preserved a straightforward one-share-one-vote structure with an independent-board majority.

agilon health Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔